How is moderate tricuspid valve regurgitation treated?

The treatment for moderate tricuspid regurgitation is a comprehensive process, mainly including the following aspects: 1. Follow-up observation: If the patient has no obvious symptoms and cardiac function is normal, regular echocardiographic examinations should be conducted as directed by a physician to monitor disease progression. 2. Medication therapy: For patients exhibiting symptoms related to right ventricular dysfunction (e.g., lower limb edema, fatigue, jugular venous distension), diuretics (e.g., furosemide), cardiotonic agents, and vasodilators (e.g., nitroglycerin) may be used to reduce cardiac load and enhance heart function. However, potential drug side effects such as hypokalemia and headache should be closely monitored. 3. Surgical treatment: If medical therapy proves ineffective or if the patient has congenital structural abnormalities, surgical intervention may be considered, such as tricuspid annuloplasty or tricuspid valve replacement, to improve tricuspid valve function and prevent further progression of regurgitation. Patients should seek timely medical attention and select appropriate treatment options under the guidance of a physician.